cv 3988 has been researched along with angiotensin ii in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, SW; Chen, CR; Voelkel, NF | 1 |
| Chang, SW; Henson, PM; McMurtry, IF; Pfeffer, KD; Voelkel, NF; Worthen, SG | 1 |
2 other study(ies) available for cv 3988 and angiotensin ii
| Article | Year |
|---|---|
Pulmonary vascular reactivity: effect of PAF and PAF antagonists.
Topics: Angiotensin II; Animals; Azepines; Hypoxia; In Vitro Techniques; Male; Phospholipid Ethers; Platelet Activating Factor; Pulmonary Circulation; Pulmonary Edema; Quinolinium Compounds; Rats; Rats, Sprague-Dawley; Triazoles; Vasoconstriction; Vasodilation | 1992 |
PAF antagonists: different effects on platelets, neutrophils, guinea pig ileum and PAF-induced vasodilation in isolated rat lung.
Topics: Alprazolam; Angiotensin II; Animals; Blood Platelets; Dose-Response Relationship, Drug; Guinea Pigs; Ileum; Muscle Contraction; Neutrophils; Phospholipid Ethers; Platelet Activating Factor; Platelet Membrane Glycoproteins; Pulmonary Artery; Pulmonary Circulation; Rabbits; Rats; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Serotonin; SRS-A; Thiazoles; Vasodilation | 1986 |